RX-1 Rhythm Express Remote Cardiac Monitoring System vs Eko Low Ejection Fraction Tool (ELEFT)

Tool B (ELEFT) integrates seamlessly into a clinician's existing workflow by utilizing a digital stethoscope during routine physical exams, providing results in approximately 15 seconds. Tool A (RX-1 Rhythm Express) requires patients to wear a patch for extended periods, which, while offering continuous monitoring, may present more patient-side usability considerations compared to a quick, non-invasive screening.

Tool A (RX-1 Rhythm Express) offers comprehensive diagnostic value through continuous 2-channel ECG monitoring in multiple modes (MCT, Event, Holter), enabling the detection of a broad range of arrhythmias over extended periods. While Tool B (ELEFT) provides crucial early detection of low ejection fraction, Tool A's multi-mode, continuous monitoring offers a wider diagnostic scope for various cardiac rhythm disorders.

Tool A (RX-1 Rhythm Express) provides transparent and flexible pricing models, including subscription, fee-for-service, and split-bill options, allowing clinics to choose the structure that best aligns with their operational and billing preferences. Tool B (ELEFT) requires direct contact for pricing, indicating less upfront transparency and potentially more complex enterprise-level negotiations.

Tool B (ELEFT) is explicitly stated to be part of Eko's SENSORAu2122 Cardiac Early Detection Platform, an enterprise solution, indicating it is designed and supported for larger-scale deployments within healthcare systems. While Tool A (RX-1 Rhythm Express) possesses essential compliance (FDA, HIPAA, BAA) and a cloud platform, Tool B's explicit positioning as an 'enterprise solution' suggests a more tailored approach for organizational integration.

Tool B (ELEFT) demonstrates significant innovation by integrating an AI algorithm for low ejection fraction detection directly into a routine physical exam via a digital stethoscope, making advanced screening accessible at the point of care. While Tool A (RX-1 Rhythm Express) features innovative MDSPu2122 technology for noise suppression, Tool B's approach offers a more disruptive change to clinical workflow by embedding AI diagnostics into a standard, non-invasive tool.

Both VivaQuant and Eko Health appear to offer standard customer and technical support channels, including access to documentation such as user manuals and FAQs. Without more specific details regarding the depth, responsiveness, or breadth of their support services, it is difficult to definitively distinguish a winner in this dimension.